A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FRAGOSO, Maria Candida Barisson Villares et al. Genetics of primary macronodular adrenal hyperplasia. Journal of Endocrinology, v. 224, n. 1, p. R31-R43, 2015Tradução . . Disponível em: https://doi.org/10.1530/joe-14-0568. Acesso em: 14 nov. 2024.
APA
Fragoso, M. C. B. V., Alencar, G. A., Lerario, A. M., Bordeaux, I., Almeida, M. Q., Mendonça, B. B., & Lacroix, A. (2015). Genetics of primary macronodular adrenal hyperplasia. Journal of Endocrinology, 224( 1), R31-R43. doi:10.1530/joe-14-0568
NLM
Fragoso MCBV, Alencar GA, Lerario AM, Bordeaux I, Almeida MQ, Mendonça BB, Lacroix A. Genetics of primary macronodular adrenal hyperplasia [Internet]. Journal of Endocrinology. 2015 ; 224( 1): R31-R43.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1530/joe-14-0568
Vancouver
Fragoso MCBV, Alencar GA, Lerario AM, Bordeaux I, Almeida MQ, Mendonça BB, Lacroix A. Genetics of primary macronodular adrenal hyperplasia [Internet]. Journal of Endocrinology. 2015 ; 224( 1): R31-R43.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1530/joe-14-0568
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALENCAR, Guilherme Asmar et al. ARMC5 mutation are a frequent cause of primary macronodular adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism, v. 99, n. 8, p. E1501-E1509, 2014Tradução . . Disponível em: https://doi.org/10.1210/jc.2013-4237. Acesso em: 14 nov. 2024.
APA
Alencar, G. A., Lerario, A. M., Nishi, M. Y., Mariani, B. M. de P., Almeida, M. Q., Tremblay, J., et al. (2014). ARMC5 mutation are a frequent cause of primary macronodular adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism, 99( 8), E1501-E1509. doi:10.1210/jc.2013-4237
NLM
Alencar GA, Lerario AM, Nishi MY, Mariani BM de P, Almeida MQ, Tremblay J, Hamet P, Zerbini MCN, Gomes GC, Bordeau I, Pereira MAA, Rocha M de S, Chambo JC, Lacroix A, Mendonça BB, Fragoso MCBV. ARMC5 mutation are a frequent cause of primary macronodular adrenal hyperplasia [Internet]. Journal of Clinical Endocrinology and Metabolism. 2014 ; 99( 8): E1501-E1509.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1210/jc.2013-4237
Vancouver
Alencar GA, Lerario AM, Nishi MY, Mariani BM de P, Almeida MQ, Tremblay J, Hamet P, Zerbini MCN, Gomes GC, Bordeau I, Pereira MAA, Rocha M de S, Chambo JC, Lacroix A, Mendonça BB, Fragoso MCBV. ARMC5 mutation are a frequent cause of primary macronodular adrenal hyperplasia [Internet]. Journal of Clinical Endocrinology and Metabolism. 2014 ; 99( 8): E1501-E1509.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1210/jc.2013-4237
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FRAGOSO, Maria Candida B. V. et al. Combined expression of BUB1B, DLG7, and PINK1 as predictors of poor outcome in adrenocortical tumors: validation in a Brazilian cohort of adult and pediatric patients. European Journal of Endocrinology, v. 166, n. 1, p. 61-67, 2012Tradução . . Disponível em: https://doi.org/10.1530/EJE-11-0964. Acesso em: 14 nov. 2024.
APA
Fragoso, M. C. B. V., Almeida, M. Q., Mazzuco, T. L., Mariani, B. M. P., Brito, L. P., Gonçalves, T. C., et al. (2012). Combined expression of BUB1B, DLG7, and PINK1 as predictors of poor outcome in adrenocortical tumors: validation in a Brazilian cohort of adult and pediatric patients. European Journal of Endocrinology, 166( 1), 61-67. doi:10.1530/EJE-11-0964
NLM
Fragoso MCBV, Almeida MQ, Mazzuco TL, Mariani BMP, Brito LP, Gonçalves TC, Alencar GA, Lima L de O, Faria AM, Bourdeau I, Lucon AM, Freire DS, Latronico AC, Mendonca BB, Lacroix A, Lerario AM. Combined expression of BUB1B, DLG7, and PINK1 as predictors of poor outcome in adrenocortical tumors: validation in a Brazilian cohort of adult and pediatric patients [Internet]. European Journal of Endocrinology. 2012 ; 166( 1): 61-67.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1530/EJE-11-0964
Vancouver
Fragoso MCBV, Almeida MQ, Mazzuco TL, Mariani BMP, Brito LP, Gonçalves TC, Alencar GA, Lima L de O, Faria AM, Bourdeau I, Lucon AM, Freire DS, Latronico AC, Mendonca BB, Lacroix A, Lerario AM. Combined expression of BUB1B, DLG7, and PINK1 as predictors of poor outcome in adrenocortical tumors: validation in a Brazilian cohort of adult and pediatric patients [Internet]. European Journal of Endocrinology. 2012 ; 166( 1): 61-67.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1530/EJE-11-0964
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Lorena de Oliveira et al. Clinical and molecular aspects of a pediatric metachronous adrenocortical tumor. Arquivos Brasileiros de Endocrinologia e Metabologia, v. 55, n. 1, p. 72-77, 2011Tradução . . Disponível em: https://doi.org/10.1590/s0004-27302011000100010. Acesso em: 14 nov. 2024.
APA
Lima, L. de O., Lerario, A. M., Alencar, G. A., Brito, L. P., Almeida, M. Q., Domenice, S., et al. (2011). Clinical and molecular aspects of a pediatric metachronous adrenocortical tumor. Arquivos Brasileiros de Endocrinologia e Metabologia, 55( 1), 72-77. doi:10.1590/s0004-27302011000100010
NLM
Lima L de O, Lerario AM, Alencar GA, Brito LP, Almeida MQ, Domenice S, Latronico AC, Mendonca BB, Fragoso MCBV. Clinical and molecular aspects of a pediatric metachronous adrenocortical tumor [Internet]. Arquivos Brasileiros de Endocrinologia e Metabologia. 2011 ; 55( 1): 72-77.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1590/s0004-27302011000100010
Vancouver
Lima L de O, Lerario AM, Alencar GA, Brito LP, Almeida MQ, Domenice S, Latronico AC, Mendonca BB, Fragoso MCBV. Clinical and molecular aspects of a pediatric metachronous adrenocortical tumor [Internet]. Arquivos Brasileiros de Endocrinologia e Metabologia. 2011 ; 55( 1): 72-77.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1590/s0004-27302011000100010
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA, Madson Queiroz et al. Long-term treatment of familial male-limited precocious puberty (testotoxicosis) with cyproterone acetate or ketoconazole. Clinical Endocrinology, v. 69, n. 1, p. 93-98, 2008Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2265.2007.03160.x. Acesso em: 14 nov. 2024.
APA
Almeida, M. Q., Brito, V. N., Lins, T. S. S., Guerra-Júnior, G., Castro, M. de, Antonini, S. R., et al. (2008). Long-term treatment of familial male-limited precocious puberty (testotoxicosis) with cyproterone acetate or ketoconazole. Clinical Endocrinology, 69( 1), 93-98. doi:10.1111/j.1365-2265.2007.03160.x
NLM
Almeida MQ, Brito VN, Lins TSS, Guerra-Júnior G, Castro M de, Antonini SR, Arnhold IJP, Mendonça BB, Latronico AC. Long-term treatment of familial male-limited precocious puberty (testotoxicosis) with cyproterone acetate or ketoconazole [Internet]. Clinical Endocrinology. 2008 ; 69( 1): 93-98.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1111/j.1365-2265.2007.03160.x
Vancouver
Almeida MQ, Brito VN, Lins TSS, Guerra-Júnior G, Castro M de, Antonini SR, Arnhold IJP, Mendonça BB, Latronico AC. Long-term treatment of familial male-limited precocious puberty (testotoxicosis) with cyproterone acetate or ketoconazole [Internet]. Clinical Endocrinology. 2008 ; 69( 1): 93-98.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1111/j.1365-2265.2007.03160.x